As the traditional healthcare model begins the shift from cure to prevention, there are several areas in which the promise of regenerative medicine can take advantage.
Neurosurgeons Adel Malek, M.D., Ph.D., and Carl Heilman, M.D., were recognized for their eShunt System, which is the first minimally invasive treatment for communicating hydrocephalus.
EU MDR has increased the regulatory burden for medical device companies, but it can also serve as a catalyst for innovation and an opportunity to streamline clinical evaluation workflows through the adoption of digitalization and AI-powered automation.
Although the future is exciting, it also poses real challenges. More collaborative initiatives need to take place between drug manufacturers and developers of manufacturing equipment and consumables.
Combining imaging technology with artificial intelligence can help address both challenges in healthcare disparities as well as in patient care.